WO1999044488A2 - Optical stretcher - Google Patents
Optical stretcher Download PDFInfo
- Publication number
- WO1999044488A2 WO1999044488A2 PCT/US1999/004845 US9904845W WO9944488A2 WO 1999044488 A2 WO1999044488 A2 WO 1999044488A2 US 9904845 W US9904845 W US 9904845W WO 9944488 A2 WO9944488 A2 WO 9944488A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- cell
- laser
- particle
- particles
- Prior art date
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 55
- 201000011510 cancer Diseases 0.000 claims abstract description 11
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 10
- 239000002245 particle Substances 0.000 claims description 81
- 238000000034 method Methods 0.000 claims description 35
- 230000008569 process Effects 0.000 claims description 18
- 239000013307 optical fiber Substances 0.000 claims description 13
- 230000001965 increasing effect Effects 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 5
- 239000012736 aqueous medium Substances 0.000 claims description 3
- 230000008093 supporting effect Effects 0.000 claims description 3
- 238000011179 visual inspection Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 278
- 239000000835 fiber Substances 0.000 description 70
- 210000003743 erythrocyte Anatomy 0.000 description 34
- 210000004292 cytoskeleton Anatomy 0.000 description 28
- 239000000243 solution Substances 0.000 description 22
- 238000002474 experimental method Methods 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 230000005855 radiation Effects 0.000 description 16
- 238000012576 optical tweezer Methods 0.000 description 14
- 238000004364 calculation method Methods 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 239000011324 bead Substances 0.000 description 10
- 239000000872 buffer Substances 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000012528 membrane Substances 0.000 description 8
- 102000007469 Actins Human genes 0.000 description 7
- 108010085238 Actins Proteins 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 238000005339 levitation Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 210000002569 neuron Anatomy 0.000 description 7
- 230000003204 osmotic effect Effects 0.000 description 7
- 238000000418 atomic force spectrum Methods 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 238000002135 phase contrast microscopy Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000011835 investigation Methods 0.000 description 4
- 238000000651 laser trapping Methods 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000003436 cytoskeletal effect Effects 0.000 description 3
- 239000003989 dielectric material Substances 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 239000012737 fresh medium Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000013101 initial test Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 210000003632 microfilament Anatomy 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 210000003463 organelle Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 230000001902 propagating effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000001857 anti-mycotic effect Effects 0.000 description 2
- 239000002543 antimycotic Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 210000002288 golgi apparatus Anatomy 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000009022 nonlinear effect Effects 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 108700038288 rhodamine-phalloidin Proteins 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000003518 stress fiber Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 241000224495 Dictyostelium Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 235000014820 Galium aparine Nutrition 0.000 description 1
- 240000005702 Galium aparine Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 206010064912 Malignant transformation Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 102000019997 adhesion receptor Human genes 0.000 description 1
- 108010013985 adhesion receptor Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000005492 condensed matter physics Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000005520 electrodynamics Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000005308 flint glass Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000036212 malign transformation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000013580 millipore water Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000004272 stretch cell Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000005469 synchrotron radiation Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
- H05H3/00—Production or acceleration of neutral particle beams, e.g. molecular or atomic beams
- H05H3/04—Acceleration by electromagnetic wave pressure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/32—Micromanipulators structurally combined with microscopes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1493—Particle size
- G01N2015/1495—Deformation of particles
Definitions
- One of the first stable traps was the levitation of particles with a vertical laser beam (Ashkin A., Dziedzic J.M., "Optical Levitation by Radiation Pressure” Appl. Phys. Lett. 19(6), p.283-285 (1971); Ashkin A., “The Pressure of Laser Light” Sci. Am. 226, p.63-71 (1972); Ashkin A., Dziedzic J.M., “Optical Levitation in High Vacuum” App. Phys. Lett. 28(6), p.333-335 (1976); Ashkin A., Dziedzic J.M., "Observation of Light Scattering from Nonspherical Particles Using Optical Levitation” Appl. Opt. 19(5), p.660-668 (1980)).
- the scattering force is strong enough to balance gravity while the gradient force keeps the particle on the optical axis.
- This one-beam setup has been studied extensively (Ashkin A., Dziedizic J.M., Bjorkholm J. E. , Chu S., "Observation of a Single-Beam Force Optical Trap for Dielectric Particles” Opt. Lett. 11(5), p.288-290 (1986); Ashkin A., "Forces of a Single-Beam Gradient Laser trap on a Dielectric Sphere in the Ray Optics Regime" Biophys. J. 61, p.569-582 (1992); Wright W. H., Sonek G.J., Berns M.
- the diameter of the particle has to be smaller than the beam radii in the center.
- the force closer to the waist of the beam is smaller than further away due to the divergence of the beam. This leads to an amplification of small displacements of the sphere from the center which means that the particle is not stably trapped (Roosen G., "A Theoretical and Experimental Study of the Stable Equilibrium Positions of Spheres Levitated by Two Horizontal Laser Beams" Opt. Comm. 21(1), p.189-195 (1977)).
- Optical Spanner (Padget M., Allen L., "Optical Tweezers and Spanners" Physics World, p.35-38 (September 1997)).
- the basic setup is as for the Optical Tweezer but instead of a Hermite-Gaussian laser profile, a Laguerre-Gaussian profile is used.
- These beams have a circular cross-section, a helical wavefront, and a Poynting vector that spirals around the axis. This means that such a beam has an orbital momentum in addition to the translational momentum previously discussed. Since the angular momentum of the system has to be conserved too, the particle starts to rotate. In this way particles can not only be translated but also rotated.
- These traps are extremely useful for all kinds of manipulation of objects, they can only translocate and/or rotate them and are not intended to deform them.
- the Optical Stretcher of this invention expands the line of optical tools and allows for a full spectrum of particle manipulation.
- AFM Atomic Force Microscope
- the present invention provides a solution to one or more of the disadvantages and deficiencies described above.
- Optical Stretcher it is possible to measure the elasticity of deformable objects, such as cells, with diameters typically between 5-50 microns.
- Optical Stretcher refers to the invention described herein. Cells owe their stability to a three-dimensional network of filamentous polymers, known as the cytoskeleton.
- the Optical Stretcher may be used for the analytical detection of single malignant cells. Cancer cells are shown to modify their morphology compared to normal cells which changes their elasticity. This novel tool, the Optical Stretcher, will be useful in detecting these changes.
- the Optical Stretcher is a novel technique to measure the elasticity of single cells which avoids the disadvantages mentioned above.
- the principle idea is to use two counter- propagating laser beams to trap a single cell, which is suspended in a buffer solution, by radiation pressure.
- the feasibility of the trapping itself was already demonstrated by A. Ashkin in the late 1960s. Since then, the trapping of all kinds of particles with sizes ranging from Angstroms (such as atoms and molecules) to tens of microns (such as small glass beads or cells) has found many applications. This is the first time that this setup is used not only for trapping, moving, and rotating particles, but for the deformation of the particle under investigation in a noninvasive, nondestructive, and controlled way.
- this invention is an apparatus, comprising: a stage capable of supporting micron-sized dielectric particles; two or more sources of laser light directed toward an area of the stage where the particles are located; a first detector which determines whether a particle is trapped between the first and second laser sources; a second detector which determines and/or measures deformation of a particle upon increasing intensity of the laser light; wherein the first and second laser sources may be adjusted to vary the power of the laser light to thereby either trap a particle or stretch the particle.
- the dielectric particles to be used in the practice of this invention may vary widely from inanimate particles such as polymer beads such as latex or polystyrene beads to biological cells such as red blood cells and nerve cells.
- this invention is an apparatus comprising a stage capable of supporting biological cells in an aqueous medium, first and second sources of laser light directed toward an area of the stage where the cells are located, a first detector which determines whether a cell is trapped between the first and second laser sources, and a second detector which determines and/or measures deformation of a cell upon increasing intensity of the laser light whereas the first and second laser sources may be adjusted to vary the power of the laser light to thereby either trap a cell or stretch the cell.
- this invention is a process for the controlled deformation of biological cells.
- This process may be comprised of exposing a cell to two counte ⁇ ropogating laser beams at an intensity sufficient to deform the cell, and optionally measuring the deformation of the cell.
- this invention is a process for the detection of individual cancer cells by measuring their deformability using the apparatus described above.
- this invention is a process for the controlled deformation of micron-sized dielectric particles, comprising: exposing a particle to two or more counte ⁇ ropogating laser beams at an intensity and under conditions effective to deform the particle; and optionally measuring the deformation of the particle.
- this invention is a process for the controlled deformation of dielectric micron-sized particles comprising exposing a particle to several laser beams at an intensity sufficient to deform the particle and optionally measuring the deformation of the cell.
- FIG. 1 shows a non-limiting, representative configuration for the apparatus of the invention.
- FIGS. 2A-2C show a non-limiting, representative perspective, top and side views of a stage that may be used in the practice of this invention.
- the Optical Stretcher is a novel optical tool which uses one or more laser beams to pull on transparent, dielectric materials.
- a set up with two or more counter propagating beams can be used to stably trap and stretch micron-sized dielectric particles such as biological cells.
- the fact that the photon pressure of a laser beam entering or leaving a medium of higher refractive index pulls on the interface is unexpected, but can be explained by momentum conservation.
- the type of cells that may be trapped and stretched may vary widely.
- this invention may be used to trap and deform eukaryotic cells including mammalian cells, except for muscle and neuronal cells which are too big for the stage shown herein.
- a representative, non-limiting list of such cells for use in the practice of this invention include epithelial cells, lymphocytes, macrophages, fibroblasts, PC 12 cells, keratinocytes and melanoma cells. It may also be possible to use small tissue clusters with a diameter of about 100 microns.
- a first laser 10 such as an Ar + -Laser (Spectra Physics Lasers, Inc., Beamlok 2080 RS), with up to 28 W power to pump, pumps a laser 12 such as a tunable, cw Ti- Sapphire Laser (Spectra Physics Lasers, Inc., 3900S having a wavelength of about 790 nanometers). While other wavelengths may be employed, we have found that for the stretching of live biological cells, a wavelength of from about 700 nanometers to about 900 nanometers, preferably from about 940 nanometers to about 840 nanometers. Two mirrors 14, 15 (Newport Co ⁇ .) are used for the height adjustment of the laser beam 16.
- Ar + -Laser Spectra Physics Lasers, Inc., Beamlok 2080 RS
- a laser 12 such as a tunable, cw Ti- Sapphire Laser (Spectra Physics Lasers, Inc., 3900S having a wavelength of about 790 nanometers). While other wavelengths may be employed, we have found that for the stretching
- the beam 16 is modulated a modulator 18 such as by an Acousto Optic Modulator (AOM) (IntraAction, AOM-802N), split in two 16a, 16b by a beam-splitter 20 (Newport Co ⁇ .) and then coupled into optical fibers 22, 24.
- the modulator 18 serves to regulate the laser power, and may be controlled by the computer 32 through the modulator driver 24.
- the fiber couplers 23, 25 were purchased from Oz Optics Ltd., the single-mode and multi-mode optical fibers from Newport.
- the optical fibers were connected to a stage (a flow chamber) 20.
- the flow chamber serves as a stage for the trapping and deformation of cells, and from which said trapping and detection may be detected (observed manually, electronically, automatically or otherwise).
- the beams 16a, 16b were directed at a sample guided by optical fibers 22, 24.
- the fibers are arranged so that counte ⁇ ropogating beams are directed at one another. That is, the beams are precisely directed at each other. This enables trapping and deformation of a cell to occur. It is believed that the gradient provided by the beams brings about the stretching of the cell as the gradient forces pull the dielectric materials that make up the cell to the point of highest intensity. Prior attempts to use light to deform (stretch) the cell led to destruction of the cell because the intensity of the beam was too strong. In prior methods, for instance, optics were used to focus (intensify) the beam to restrict the divergence of the beam after leaving the laser.
- the gradient forces are minimal.
- the higher refractive index of the cell leads to a change in momentum that leads to scattering forces.
- the increased momentum of the beam in the cell is compensated for by the cells stretching in the direction of the beam.
- An alternative to the flow chamber in FIGS. 1 and 2A-2C a a third channel in the z-direction may be bored of elliptical profile.
- the channels for the fibers, flow of cells and elliptical profile cross paths as depicted by dotted lines in FIGS. 2B and 2C. If a cell blocks the elliptical channel, conductance along this channel will go down.
- the flow chamber 40 for use in the configuration of FIG. 1 may have the size of an optical microscopy slide, but the dimensions may vary widely.
- the stage may include one or more microscope slides that are secured to the top 48 and/or bottom 49 of the stage 40.
- the flow chamber 40 is bored to provide channels 42 in which the optical fibers 22, 24 are inserted.
- the channels 42 serve to guide the fibers.
- Another channel 44 generally pe ⁇ endicular to the guidance channels 42, serves to form a conduit through which the stream of cells are flowed.
- the cell 44 and guidance 42 channels may be considered to be formed in the xy-plane.
- a third bore 46 may also be made in the z-plane, which bisects the intersection of the cell 44 and guidance 42 channels.
- the bore 46 serves to form an aperture for illumination for phase contrast microscopy.
- the third bore 46 may be of elliptical dimension, with electrodes being suitably attached for conductance measurement.
- the Optical Stretcher itself was set up on an inverted microscope (Zeiss Axiovert TV 100) equipped for phase contrast and fluorescence microscopy. We used an Olympus 20X objective to control the overall setup. The microscope serves to both detect the trapping and stretching of the cell. While a microscope is shown in FIG. 1 , other devices, such as devices that measure conductance, may be used. The low magnification of this objective is ideal for checking the alignment of the fibers and to trap cells. For the observation of the small deformations of the cells we used a Zeiss LD Achroplan (40X, NA 0.60) with different additional magnification lenses.
- Phase-contrast microscopy is one of them and the one we used in the experiments unless otherwise stated.
- An additional benefit of phase-contrast microscopy is that sizes of objects can be determined with an accuracy of tens of nanometers - much less than the optical resolution in light microscopy.
- phase contrast microscopy objects seem to have a bright halo around them. The jump in contrast is therefore very steep and can easily be detected with the well known, appropriate image processing software. This fact was used to determine the deformations of the cells.
- Images were obtained with a CCD camera (MTI- Dage CCD72S), connected to the microscope by a 4X coupler, and recorded on a SVHS recorder 30 (Panasonic DS550).
- the camera is optionally used.
- the output from the camera is digitized and analyzed by the computer for the degree of stretching.
- the microscope may operate in the phase contrast mode, with objectives of 20X and 40x magnification being used in one embodiment of this invention.
- These images were then evaluated on a PowerComputing computer (PowerTower Pro 225) with NIH-Scion Image software (V 1.60).
- the pixel size for all used magnifications was calibrated with a 100 lines/mm grating which allowed for absolute distance measurements.
- AOM acousto-optic modulator
- the main part of an AOM is a crystal with appropriate transmittance (in our case, dense flint glass for high transmittance in the range from 700 - 1300 nm).
- a RF frequency signal is applied to this crystal through an piezoelectric transducer, a sound wave (wavelength ⁇ ) travels through it and creates a standing wave.
- This standing wave produces a density grating in the crystal.
- the frequency /of the RF signal is chosen in a way that the wavelength of the grating is on the order of the optical wavelength of the light ⁇ .
- An AOM can be used for deflection, intensity control, and optical frequency shifting of a laser beam, as well as multiple beam generation.
- SM single mode
- MM multimode
- a SM fiber is usually the best choice (Constable A., Kim J., Mervis J., Zarinetchi F., Prentiss M., "Demonstration of a Fiber-Optical Light-Force Trap” Opt. Lett. 18(21), p.1867-1869 (1993)). Also, if the mode quality of the laser beam is not very good, the SM fiber serves as spatial filter and guarantees a clean Gaussian profile.
- SM fibers One disadvantage of a SM fiber is that it is harder to couple the beam into the fiber (the possible coupling efficiency is only about half of that of MM fibers), and it is not possible to transmit as high light powers.
- the highest transmitted powers in this invention with the SM fiber have thusfar been about 200 mW for an input power of 2.5 W.
- the MM fiber With the MM fiber the invention may able to transmit more than 500 mW.
- these fibers are especially designed for a certain wavelength band.
- the mode-field-diameter which is the diameter of the part of the fiber actually carrying light is directly related to the wavelength band: the shorter the wavelength the smaller the mode-field-diameter. This means that one is restricted to a certain beam size once a certain operating wavelength is chosen.
- MM fibers there is no fixed relation between wavelength and mode-field-diameter so that this is an additional parameter which can be varied.
- the fibers are also the most fragile technical component of the setup.
- the diameter of the stripped fiber is only 125 micron and breaks very easily.
- the optical performance of the fiber depends strongly on the quality of the ends. They have to be very flat and ideally pe ⁇ endicular to the axis. At present, we have used a very simple fiber cleaver (Siecor Co ⁇ ., FBC 001), which gave satisfying results, although it usually took several attempts.
- the alignment of the fibers is very crucial. If they are not coaxially aligned, a misalignment on the order of 1 micron is enough, the cell cannot be trapped stably.
- the solution described in Constable A., Kim J., Mervis J., Zarinetchi F., Prentiss M., "Demonstration of a Fiber-Optical Light-Force Trap” Opt. Lett. 18(21), p.1867-1869 (1993) may be used to achieve the required accuracy: Glass pipettes were heated up and then pulled out to diameters of 250 - 400 ⁇ m. This small capillary was glued down on a coverslide and the fibers were pressed against it. Sitting in this V-groove they were facing each other with the appropriate accuracy. We filled the capillaries with black ink to reduce the light which was scattered from them. This increased the visibility of the cells and their deformation.
- the abso ⁇ tion of chromophores which is the term for predominantly absorbing components in a cell, is low in the IR and increases with decreasing wavelength.
- the main content of an average cell is water (-70% of the weight) which absorbs increasingly with larger wavelength.
- the abso ⁇ tion of light and thus thermal problems should be minimized. For this reason, we use a Ti-Sapphire laser at its peak emission at about 790 nm. With the tunability from 600-1000 nm we can in principle cover the whole region of interest.
- nonlinear effects could come into play.
- nonlinear optical processes occur at very high light intensities where two (or more) photons with a certain energy can excite the same transitions as one photon with twice (or several times) this energy.
- Pulsed Ti-Sapphire lasers are used in two-photon spectroscopy to exactly excite these UV abso ⁇ tion bands of proteins.
- the intensities are still far away from the intensities encountered with pulsed lasers and the intensities needed for multi-photon excitation since a cw laser is used and the beam is not focused. Consequently, these nonlinear effects can be neglected and should not cause any problems.
- There is still the danger of inducing some kind of photochemistry A possible scenario is that oxygen is broken into radicals which are extremely toxic for cell processes. These effects are not well understood at all.
- RBC red blood cells
- RBCs only have a thin layer of cytoskeleton right beneath their membrane and no three-dimensional network of polymers throughout the cell volume. Thus, they are much softer than real cells and it is easier to observe deformations of the cell shape. This made them a perfecy choice as initial test objects. All chemicals, unless otherwise stated, were purchased from Sigma.
- the buffer used for the RBCs was 100 mM NaCl, 20 mM Hepes buffer, 25 mM Glucose, 5 rnM KC1, 3 mM CaCl 2 , 2 mM MgCl 2 , 0.1 mM Adenine, 0.1 mM Inosine, 1% (volume) Antibiotic- Antimycotic solution, 0.25-1.5%) Albumin, and 5 units/ml Heparin.
- This buffer was adapted from Strey H., Betician elastischer yoga von Zellmembranen und Zytoskelett using Flickerspektroskopie, Ph. D.
- the shape can change depending on the osmolarity of the buffer. If the buffer conditions change to hypotonic (lower concentration, i.e. osmolarity) with respect to the inside the cell starts to swell to relax the osmotic pressure and, if the new osmolarity is chosen right, assumes a spherical shape. Shortly before the actual experiment the cell solution was warmed up to room temperature and diluted by 1 :2 with Millipore water which changed the buffer conditions to hypotonic. After a short time (about five minutes), almost all RBCs had a spherical shape and were ready for usage. A spherical object with its rotational symmetry is preferable over other possible geometries for trapping and deformation because its interaction with light and the calculation of the corresponding forces is less complicated.
- the first cells used were nerve cells (PC 12 rat nerve cells). In contrast to RBCs, these cells have all organelles such as nucleus, mitochondria, and Golgi apparatus normally found in a cell. They also have a three-dimensional cytoskeleton throughout the whole cell body which results in a higher mechanical strength. Nerve cells in vivo usually have two types of extensions which are called axons and dendrites. The nerve cells had not been differentiated yet and did not show these extensions. These cells are cultured in petri dishes and are usually attached to the surface and clustered together.
- DMEM Dulbecco's Modified Eagle's Medium
- FBS fetal bovine serum
- Antibiotic- Antimycotic solution Penicillin/Streptomycin
- TRED Trypsin-EDTA solution
- Trypsin is a protease which degrades the extracellular matrix and also adhesion receptors.
- EDTA is a chelating (binding) agent for divalent cations (Ca 2+ , Mg 2+ ) required for the proper conformation of these receptors.
- TRED Trypsin is a protease which degrades the extracellular matrix and also adhesion receptors.
- EDTA is a chelating (binding) agent for divalent cations (Ca 2+ , Mg 2+ ) required for the proper conformation of these receptors. The procedure is as follows: First the medium is carefully aspirated off the tissue culture dish.
- lOmM phosphate buffered saline PBS
- Trypsin inhibitors Ca 2+ , Mg 2+ , serum
- TRED Trypsin inhibitors
- Rhodamine- Phalloidin TRITC
- DMSO DMSO
- Rhodamine-Phalloidin is a fluorescent tag that selectively binds to actin filaments and not to actin monomers.
- non-deformable particles glass beads, latex beads
- the goal was solely to trap, hold, move, and/or rotate these particles. What no one has tried so far is to use these forces that arise with the interaction of light and matter to deform particles in a controlled way.
- Biological cells are potentially deformable objects. In fact, they must be to perform their tasks in vivo. Their amazing elasticity against external pressure is what we want to elucidate. The idea was to use a two beam setup as described above to capture and hold a single cell and then to increase the light power to the point where the radiation pressure starts to deform the cell.
- the model cell is assumed to be a spherical, uniform, and lossless dielectric particle with a certain index of refraction n 2 suspended in a fluid with refractive index n,. Cells are also rather transparent and hard to see in a through-light microscope which makes the assumption of a non- absorbing particle plausible. The uniformity of the particle is a necessary assumption to keep the calculation simple, but is questionable for a cell with all its small localized structures.
- (31) r( ⁇ ) ⁇ n ⁇ sin ⁇ - r) + R( ⁇ ) ⁇ sin(2 ⁇ )
- the refracted rays do not stop inside (abso ⁇ tion is neglected) but exit the particle on the other side.
- the sphere acts as a lens and collects them close to the axis. The forces at this boundary are also pointing away from the surface.
- the next step is to take the Gaussian profile of the beam into account. This simply means that the power P of a ray with a certain distance d from the axis has to be multiplied by,
- V w J where w is the beam radius.
- the center of the particle is assumed to be on the optical axis.
- the cytoskeleton in a cell which is connected to the membrane, will act as a spring and build up a restoring tension.
- the forces on the surface will change corresponding to the deformation until the system reaches equilibrium.
- the final form of the particle is expected to look like an ellipsoid with the major axis in the direction of the beam axis.
- this effect is similar to the case where a dielectric fluid is pulled into the field between two capacitor plates because it is an energetically favorable position.
- the cell is also pulled into the region of higher fields, i.e. the center of the laser beam.
- the powers transmitted by the SM fiber we measured the powers transmitted by the SM fiber to be up to 220 +/- 20 mW. Inserting this value into equation (20) for the momentum of the light we obtained the following force profile on both sides of the sphere when it is trapped in between two laser beams of equal light power.
- the beam radius and the sphere radius in this case are the same (p/w - 1).
- the forces in the center are on the order of 0.17 nN and decrease towards the edge of the sphere.
- the jump in the profile occurs because the second laser beam coming from the other side is collimated towards the middle.
- the intensity is related to the power by,
- the shape of the stress profile is the same as the force profile.
- the light intensities of a beam with radius 5.0 ⁇ m at the surface of a cell with the same radius are about 5.0xl0 5 W/cm 2 (SM) / 1.3xl0 6 W/cm 2 (MM) and yield force densities in the center of about 4.5 Pa and 11 Pa respectively.
- the total stress on one side of the cell that causes the deformation is the integral of the stress profile. We did this calculation numerically and obtained a total stress of 16 Pa for the 200 mW transmitted by the SM fiber, and 40 Pa for 500 mW when using the MM fiber. We will use these quantities for an estimate of the Young modulus of cells.
- the refractive index n of the trapped particle has to be higher than that of the surrounding, is fulfilled intrinsically: the n of water under normal conditions is 1.33 whereas n of cells has been reported to be in the range from 1.4 - 1.6.
- the beam radius has to be larger than the radius of the trapped object. The largest radius of a RBC that we measured was 4.0 ⁇ m.
- ⁇ 790 nm is the wavelength of the light.
- Typical fiber distances in our experiments are in the range from 100 - 300 ⁇ m > 2 z mi ⁇ so that the second stability criterion is also always fulfilled.
- PC 12 cells have diameters up to 15 ⁇ m and the required minimal fiber distance for stable trapping is 140 ⁇ m. For these cells we had to make sure that the fiber distances are sufficient for stable trapping.
- the MM fiber has a mode field diameter of 50 ⁇ m which is much larger than the diameters of all cells under investigation. Thus, cells can be trapped with MM fibers regardless of the fiber distances. It might be su ⁇ rising that we achieved stable trapping at all with the MM fiber and we will discuss that below.
- the RBC had been osmotically swollen to achieve a spherical shape and to it was applied total stress of 16+/-1 Pa.
- the stretching of the cell can easily be seen.
- the elongation along the major axis in this case was from 6.08+/-0.02 ⁇ m to 6.54+/-0.02 ⁇ m.
- This is a relative deformation ⁇ 7.6+/-0.6 %.
- We used equation (35) to obtain an estimate for the Young modulus E 210+/- 10 Pa. This value does not reflect the strength of the two-dimensional cytoskeleton of RBCs which should be much weaker, but rather the resistance by osmotic pressure.
- PC 12 cells as an arbitrary normal cell, have an extensive three-dimensional cytoskeleton, whereas RBCs only have a layer of cytoskeleton right under their membrane. Thus, it was expected that it would be much harder to deform PC 12 cells.
- the velocity in our experiment was 11.2+/-2.7 ⁇ m s at about 100 mW for RBCs with a radius of 5 ⁇ m. This velocity corresponds to a force of about 1.1+/-0.2 nN.
- the index of refraction of the cell is higher than was assumed. This would lead to an underestimation of the calculated force since the force is highly sensitive to the index of refraction, as derived herein.
- the model might be too simple. It predicts the qualitative nature of the deforming forces quite well but might be off quantitatively. Since the membrane and its constituent phospholipids have a higher refractive index than the cytoplasm, it might be more realistic to assume a spherical shell with a certain index of refraction filled with another dielectric with a refractive index lower than the shell but higher than the surrounding medium.
- a last fact that is not included in the model is that some light is absorbed when it passes through the cell. Including this would also increase the calculated net force in the forward direction because more momentum of the incident light is picked up by the cell.
- vesicles over RBCs is that we can vary the refractive index of the interior by forming the vesicles in solutions of different sugar solutions. After the vesicles have formed, the exterior of the vesicle can also be varied by changing the type of sugar dissolved in it and the sugar concentration. If the forces measured for vesicles differ qualitatively from those for glass beads, which are at presence exactly described with our model, we will have to take the shell-like nature of cells into account.
- vesicles Another possibility with vesicles is that the interior osmotic pressure of the system can be determined by changing the osmolarity of the surrounding solution. Water molecules, in contrast to charged and larger molecules, can diffuse relatively easy across the membrane. If the ionic strength of the solution outside is changed, an osmotic pressure builds up which can be precisely calculated. This is also true for the osmotic swelling of RBCs. However, when the vesicle is trapped in between two laser beams the deforming forces on the surface are solely balanced by the osmotic pressure which is not supported by a cytoskeleton as in RBCs. The membrane itself is so soft that it can be ignored. This is another possibility to directly measure the deforming stress. Viability of Cells
- the abso ⁇ tion coefficient of water is reduced by a factor of ten when 780 nm light is used instead of the 1064 nm of a Nd-YAG laser. This is important because the local heating of water is a key limiting factor for the survival of cells which, in most cases, can only survive in the temperature range from 35-42°C. However, other damaging effects, such as the direct abso ⁇ tion of light by chromophores or photochemistry, as discussed above, might come into play.
- a more careful approach is the use of a vital stain such as Trypan Blue. As long as a cell is alive it is able to prevent the dye from entering the cytosol. However, if the cell is dead or does not maintain its normal function, the dye will penetrate the cell membrane and the whole cell appears blue. We added 5% (volume) Trypan Blue to the cell solution after we had trapped and deformed the cell, and we did not observe any staining.
- a vital stain such as Trypan Blue.
- Four culture dishes were each loaded with (1.6+/-0.2)xl0 5 cells. Two of those were irradiated with 500 mW of 790 nm laser light for 5 minutes by pointing one of the MM fibers directly at the cells and the other two were kept as control.
- the cells were allowed to grow under ideal conditions in an incubator at 37°C and in an 5% CO 2 atmosphere. After four days the irradiated cells did not show any sign of difference to the control cells which had not been irradiated.
- the total number of cells per dish increased to (4.1+/-0.2) x 10 5 (control) and (4.2+/-0.3) x 10 5 (irradiated) over the period of four days. This was the strongest of the three tests because it monitored if the cells are still capable of dividing normally. All three tests prove that the cells survive the conditions in an Optical Stretcher without any detectable damage.
- Optical Stretcher Another important question for the applicability of the Optical Stretcher to measure normal cell elasticities is, whether cells maintain a cytoskeleton at all when they are trypsinized and in suspension. For a check of this condition we stained the actin cytoskeleton of living, freshly trypsinized PC 12 cell. TRITC stains exclusively actin filaments and not single monomers, and its fluorescence increases by a factor of 3 when bound to a filament. This assures that we see filamentous actin and not actin monomers. The cells do have an extensive actin network throughout the whole cell volume. Also the actin cortex can be seen at the rim of the cell. The only feature of the cytoskeleton which is not present are stress fibers. However, those should play only a minor role for the elasticity of cells.
- the Optical Stretcher really measures the elasticity of living, normal cells and preserves their integrity.
- SM versus MM All reported fiber optical realizations of light traps were built with SM fibers. The justification was that it is very important to have a Gaussian beam profile for an efficient axial confinement by the gradient force. We found it also possible to use multimode (“MM”) fibers. The profile is not Gaussian anymore but the highest intensity is still in the center and particles are attracted by this high field. The second stability criterion, that the beam diameter is larger than that of the cells, is fulfilled more easily since the mode field diameter of MM fibers (50 ⁇ m - 500 ⁇ m) is much larger than for SM fibers (5 ⁇ m).
- MM fibers are capable of transmitting more light than SM fibers, 500 mW instead of 200 mW, and thus allow for higher forces.
- MM fibers are capable of transmitting more light than SM fibers, 500 mW instead of 200 mW, and thus allow for higher forces.
- the radiation pressure of two counter-propagating laser beams of a cw Ti-Sapphire laser at 790 nm is sufficient to deform a cell which does not show any sign of detectable damage and maintains its normal cytoskeleton. Su ⁇ risingly, the cell is not squeezed but rather stretched out along the optical axis. This effect has never been observed before and can be used to distinguish between different cells.
- We also developed a simple model of the forces on the cell which predicts the force profile on its surface and qualitatively explains the observed deformations rather well.
- the total possible stress on a cell is in the range of 10 - 100 Pa for assumed relative indices of refraction between 1.1 - 1.2 and light powers up to 500 mW.
- the relative index of refraction n has a rather strong influence on the magnitude of the total stress.
- First experiments to measure the actual deforming forces indicate that the real stresses might by even higher than the calculated numbers by a factor of 20.
- the calculated cell elasticities above are first estimates and should be seen as lower bounds for the real elasticity.
- a flow chamber which will have several advantages over the present open setup (See FIG. 2).
- This chamber may be constructed out of silicon with micro-manufacturing techniques. The necessary alignment will be achieved by etching two V-grooves along the I l l-planes of the crystal. One of the grooves will lead the two fibers and will guarantee sufficient alignment. The second, pe ⁇ endicular, groove will serve as flow channel for the cell solution. A center hole will provide optical access for the observation of the trapping and deformation. Another idea is to use synchrotron radiation to "drill" the two pe ⁇ endicular channels with high accuracy into PMMA. Since PMMA is transparent the observation hole is obsolete, which in the other setup might cause problems, such as turbulence or leakage.
- Optical Stretcher can then be realized in a very small version and has the potential to be used as a clinical tool.
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Electromagnetism (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Plasma & Fusion (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Micromachines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Microscoopes, Condenser (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU28962/99A AU2896299A (en) | 1998-03-04 | 1999-03-04 | Optical stretcher |
JP2000534104A JP4456270B2 (en) | 1998-03-04 | 1999-03-04 | Optical stretcher |
EP99909852A EP1059871B1 (en) | 1998-03-04 | 1999-03-04 | Optical stretcher |
DE69926116T DE69926116T9 (en) | 1998-03-04 | 1999-03-04 | OPTICAL STRECKER |
CA002322212A CA2322212C (en) | 1998-03-04 | 1999-03-04 | Apparatus and processes for laser deformation of dielectric particles |
HK01102919A HK1032726A1 (en) | 1998-03-04 | 2001-04-24 | Optical stretcher |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7672798P | 1998-03-04 | 1998-03-04 | |
US60/076,727 | 1998-03-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999044488A2 true WO1999044488A2 (en) | 1999-09-10 |
WO1999044488A3 WO1999044488A3 (en) | 1999-12-29 |
Family
ID=22133834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/004845 WO1999044488A2 (en) | 1998-03-04 | 1999-03-04 | Optical stretcher |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1059871B1 (en) |
JP (1) | JP4456270B2 (en) |
AU (1) | AU2896299A (en) |
CA (1) | CA2322212C (en) |
DE (1) | DE69926116T9 (en) |
HK (1) | HK1032726A1 (en) |
WO (1) | WO1999044488A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005515878A (en) * | 2002-01-16 | 2005-06-02 | ユニヴァーシティ・オヴ・シカゴ | Use of multiple optical vortices for pumping, mixing and sorting |
US8183540B2 (en) | 2006-01-25 | 2012-05-22 | The Science And Technology Facilities Council | Droplet deformation |
US10571387B2 (en) | 2013-08-23 | 2020-02-25 | Zellmechanik Dresden Gmbh | Apparatus and method for determining the mechanical properties of cells |
CN111474106A (en) * | 2019-01-23 | 2020-07-31 | 香港科技大学 | Method and system for determining mechanical properties of biological cells or biological cell-like particles |
US11023705B2 (en) | 2017-04-05 | 2021-06-01 | Olympus Soft Imaging Solutions Gmbh | Method for the cytometric analysis of cell samples |
EP3889662A1 (en) * | 2020-04-03 | 2021-10-06 | Leica Microsystems CMS GmbH | Optical illumination system for a microscope and microscope |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008037713A1 (en) * | 2008-08-14 | 2010-02-18 | Systektum Gmbh | Apparatus and method for concentration analysis of the contents of drug-filled glass containers |
DE102009020144A1 (en) | 2009-05-05 | 2010-11-11 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Optical arrangement and method for moving a microscopic structure |
DE102010015083B4 (en) * | 2010-04-15 | 2012-04-12 | Eads Deutschland Gmbh | Sensor and method for online monitoring of the acid value of a hydraulic fluid in a hydraulic system in an aircraft |
DE102010023099B3 (en) | 2010-06-09 | 2011-11-17 | Celltool Gmbh | Method and device for characterizing biological objects |
DE102012211735B4 (en) | 2012-07-05 | 2015-04-09 | Universität Leipzig | Apparatus and method for characterizing cells and their use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4893886A (en) * | 1987-09-17 | 1990-01-16 | American Telephone And Telegraph Company | Non-destructive optical trap for biological particles and method of doing same |
CA2031716C (en) * | 1989-12-07 | 1996-06-18 | Hiroaki Misawa | Laser microprocessing and the device therefor |
US5079169A (en) * | 1990-05-22 | 1992-01-07 | The Regents Of The Stanford Leland Junior University | Method for optically manipulating polymer filaments |
US5245466A (en) * | 1990-08-15 | 1993-09-14 | President And Fellows Of Harvard University And Rowland Institute | Optical matter |
US5608519A (en) * | 1995-03-20 | 1997-03-04 | Gourley; Paul L. | Laser apparatus and method for microscopic and spectroscopic analysis and processing of biological cells |
-
1999
- 1999-03-04 CA CA002322212A patent/CA2322212C/en not_active Expired - Fee Related
- 1999-03-04 WO PCT/US1999/004845 patent/WO1999044488A2/en active IP Right Grant
- 1999-03-04 DE DE69926116T patent/DE69926116T9/en active Active
- 1999-03-04 JP JP2000534104A patent/JP4456270B2/en not_active Expired - Fee Related
- 1999-03-04 AU AU28962/99A patent/AU2896299A/en not_active Abandoned
- 1999-03-04 EP EP99909852A patent/EP1059871B1/en not_active Expired - Lifetime
-
2001
- 2001-04-24 HK HK01102919A patent/HK1032726A1/en not_active IP Right Cessation
Non-Patent Citations (4)
Title |
---|
ASHKIN A., "Applications of Laser Radiation Pressure", SCIENCE, (Washington, D.C.) 5 December 1980, Vol. 210, No. 4474, pages 1081-1088, XP002923517 * |
ASHKIN et al., "Radiation Pressure on a Free Liquid Surface", PHYS. REV. LETT., 22 January 1973, Vol. 30, No. 4, pages 139-142, XP002923518 * |
CONSTABLE et al., "Demonstration of a Fiber-Optical Light-Force Trap", OPTICS LETTERS, 01 November 1993, Vol. 18, No. 21, pages 1867-1869, XP000402580 * |
See also references of EP1059871A2 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005515878A (en) * | 2002-01-16 | 2005-06-02 | ユニヴァーシティ・オヴ・シカゴ | Use of multiple optical vortices for pumping, mixing and sorting |
US8183540B2 (en) | 2006-01-25 | 2012-05-22 | The Science And Technology Facilities Council | Droplet deformation |
US10571387B2 (en) | 2013-08-23 | 2020-02-25 | Zellmechanik Dresden Gmbh | Apparatus and method for determining the mechanical properties of cells |
US11023705B2 (en) | 2017-04-05 | 2021-06-01 | Olympus Soft Imaging Solutions Gmbh | Method for the cytometric analysis of cell samples |
US11776283B2 (en) | 2017-04-05 | 2023-10-03 | Olympus Soft Imaging Solutions Gmbh | Method for the cytometric analysis of cell samples |
CN111474106A (en) * | 2019-01-23 | 2020-07-31 | 香港科技大学 | Method and system for determining mechanical properties of biological cells or biological cell-like particles |
EP3889662A1 (en) * | 2020-04-03 | 2021-10-06 | Leica Microsystems CMS GmbH | Optical illumination system for a microscope and microscope |
Also Published As
Publication number | Publication date |
---|---|
CA2322212A1 (en) | 1999-09-10 |
EP1059871A4 (en) | 2001-08-01 |
EP1059871A2 (en) | 2000-12-20 |
DE69926116D1 (en) | 2005-08-18 |
JP2002505200A (en) | 2002-02-19 |
EP1059871B1 (en) | 2005-07-13 |
DE69926116T2 (en) | 2006-04-20 |
DE69926116T9 (en) | 2006-08-10 |
WO1999044488A3 (en) | 1999-12-29 |
CA2322212C (en) | 2009-05-12 |
HK1032726A1 (en) | 2001-08-03 |
JP4456270B2 (en) | 2010-04-28 |
AU2896299A (en) | 1999-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6067859A (en) | Optical stretcher | |
Guck et al. | Stretching biological cells with light | |
US11415936B2 (en) | Multiple laminar flow-based particle and cellular separation with laser steering | |
US10216144B2 (en) | Multiple laminar flow-based particle and cellular separation with laser steering | |
US8076632B2 (en) | Device and method for the contactless manipulation and alignment of sample particles in a measurement volume using a nonhomogeneous electric alternating field | |
CA2322212C (en) | Apparatus and processes for laser deformation of dielectric particles | |
US20030124516A1 (en) | Method of using optical interrogation to determine a biological property of a cell or population of cells | |
US20100108577A1 (en) | Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles | |
JPS60238762A (en) | Fluid blood corpuscle inspection device | |
JP2006506052A (en) | System and method for sorting materials using holographic laser steering | |
Unterkofler et al. | Long‐distance laser propulsion and deformation‐monitoring of cells in optofluidic photonic crystal fiber | |
Sischka et al. | Compact microscope-based optical tweezers system for molecular manipulation | |
Ferrara et al. | Experimental study of the optical forces exerted by a Gaussian beam within the Rayleigh range | |
Kas et al. | Optical stretcher | |
Cojoc et al. | Manipulation and biophysical characterization of giant unilamellar vesicles with an optical stretcher | |
Whyte et al. | Dual-beam laser traps in biology and medicine: when one beam is not enough | |
Dasgupta et al. | Optical tweezers and cytometry | |
Förster et al. | Tracking of individual Nano-objects inside Hollow Core Fibers on the example SARS-CoV-2 | |
Pesce et al. | Manipulating matter with light | |
Bowman et al. | Implementing optical tweezers at high pressure in a diamond anvil cell | |
Chiou | Experimental measurement and analysis of scattering force and gradient force in optical trapping and manipulation of micro-particles | |
静岡大学博士論文 | Statsenko Anna | |
Monajembashi et al. | Trapping of dielectric particles and cells by a fiber-coupled laser trap | |
Bakken et al. | Optical Tweezers | |
Malagnino et al. | Measurements of optical tweezers stiffness |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase in: |
Ref country code: CA Ref document number: 2322212 Kind code of ref document: A Format of ref document f/p: F Ref document number: 2322212 Country of ref document: CA |
|
ENP | Entry into the national phase in: |
Ref country code: JP Ref document number: 2000 534104 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999909852 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999909852 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999909852 Country of ref document: EP |